The company announced the results during trading hours today, 1 November 2011.

Meanwhile, the BSE sensex was provisionally down 226.88 points, or 1.28% to 17,478.13.

On BSE, 21.32 lakh shares were traded in the counter as against average daily volume of 4.5 lakh shares in past one quarter.

The stock hit a high of Rs 179 and a low of Rs 158.50 during the day.

The mid-cap pharma company has an equity capital of Rs 70.44 crore. Face value per share is Rs 10.

Commenting on the results, Mr K Raghavendra Rao, CMD, Orchid Chemicals & Pharmaceuticals said, "Our operational performance continues to tread on a strong path. The business model change that we had initiated post the injectable business transfer to Hospira last year continues to augur well with the several long-term supply contracts entered into with large global players paving the way for continued robust earnings".

Orchid Chemicals & Pharmaceuticals is a leading pharmaceutical company headquartered in Chennai. The company is involved in the development, manufacture and marketing of diverse bulk activities, formulations and nutraceuticals.